Madrigal sees road to approval for NASH drug resmetirom
pharmaphorum
DECEMBER 20, 2022
The condition is largely associated with obesity and an unhealthy diet and lifestyle, and is on the rise in industrialised nations, leading to estimates it could present a market opportunity worth tens of billions of dollars worldwide.
52 
Let's personalize your content